Facioscapulohumeral Muscular Dystrophy Whole Blood

<h2>Facioscapulohumeral Muscular Dystrophy (FSHD) Whole Blood for Research</h2>
FSHD is a genetic muscular dystrophy linked to DUX4 gene de-repression, causing progressive weakness in the face, shoulders, and upper arms. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed FSHD diagnosis for genomic and neuromuscular biomarker research.
<h3>Product Features</h3>
<ul><li>Fresh whole blood from clinically diagnosed FSHD donors</li><li>Custom anticoagulants and collection tubes available</li><li>Same-day collection and shipment</li><li>Research Use Only (RUO)</li></ul>
<h3>De-identified Donor Data</h3>
<ul><li>Physician-confirmed FSHD diagnosis, including genetic testing results where available</li><li>Demographics: age, sex assigned at birth, ethnicity</li><li>Relevant medical and family history</li></ul>
<h3>Applications</h3>
<ul><li>DUX4 gene expression and epigenetic research</li><li>Muscle-damage biomarker studies</li><li>Gene expression and transcriptomic analysis</li><li>Drug response and gene-therapy mechanism studies</li></ul>
<h3>Also Available</h3>
FSHD samples are also available as serum – contact us to discuss the right specimen type for your study.
<h3>Compliance and Quality</h3>
<ul><li>IRB-approved protocols and electronic informed consent</li><li>HIPAA-compliant donor data handling</li></ul>
<h3>Ordering and Customization</h3>
FSHD whole blood is available in standard and custom volumes. Email <a href=”mailto:learnmore@sanguinebio.com”>learnmore@sanguinebio.com</a> for international orders or documentation requirements.